RANKINGS

Lowest P/B — Healthcare

Price-to-Book ratio compares market value to book value. Lower may signal value.

181 companies with P/B Ratio data.

Ranked by P/B Ratio(181)

#	Ticker	Name	Industry	Market Cap	P/B Ratio
1	GURE	GULF RESOURCES, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$5M	0.0
2	TRAW	Traws Pharma, Inc. TTM · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$7M	0.1
3	NAII	NATURAL ALTERNATIVES INTERNATIONAL INC FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$7M	0.1
4	PMCB	PHARMACYTE BIOTECH, INC. FY · 2026-04-30 Analysis WACC DCF	Pharmaceuticals	$4M	0.2
5	BON	BON NATURAL LIFE LIMITED FY · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$9M	0.2
6	AVD	AMERICAN VANGUARD CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$47M	0.3
7	VRAX	Virax Biolabs Group Limited FY · 2025-03-31 Analysis WACC DCF	Biotechnology	$1M	0.3
8	VHI	VALHI, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$402M	0.3
9	QCLS	Q/C Technologies, Inc. FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$5M	0.3
10	TLRY	Tilray Brands, Inc. FY · 2026-05-31 Analysis WACC DCF	Pharmaceuticals	$523M	0.3
11	CRIS	CURIS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2M	0.3
12	SNDL	SNDL Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$300M	0.4
13	USNA	USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 Analysis WACC DCF	Pharmaceuticals	$271M	0.5
14	ATYR	aTYR PHARMA INC FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$24M	0.5
15	LAB	Standard BioTools Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$271M	0.5
16	MOS	MOSAIC CO TTM · 2026-06-30 Analysis WACC DCF	Other	$6.0B	0.5
17	QDEL	QUIDELORTHO CORP TTM · 2026-06-28 Analysis WACC DCF	Biotechnology	$920M	0.5
18	OGEN	ORAGENICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2M	0.6
19	ORMP	ORAMED PHARMACEUTICALS INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$180M	0.6
20	AMRN	AMARIN CORP PLC\UK FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$254M	0.6
21	FLNA	Filana Therapeutics, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$39M	0.6
22	SCYX	SCYNEXIS, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$41M	0.6
23	TENX	TENAX THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$70M	0.6
24	ACB	AURORA CANNABIS INC FY · 2025-03-31 Analysis WACC DCF	Pharmaceuticals	$284M	0.7
25	CGC	Canopy Growth Corporation FY · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$350M	0.7
26	CELZ	Creative Medical Technology Holdings, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$6M	0.7
27	CDIO	Cardio Diagnostics Holdings, Inc. TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$6M	0.7
28	COTY	COTY INC. FY · 2026-06-30 Analysis WACC DCF	Other	$2.5B	0.8
29	FMC	FMC CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.3B	0.8
30	ENVB	ENVERIC BIOSCIENCES, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$6M	0.8
31	TOVX	THERIVA BIOLOGICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$10M	0.8
32	OPK	OPKO Health, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.0B	0.9
33	ERNA	Ernexa Therapeutics Inc. FY · 2024-12-31 Analysis WACC DCF	Pharmaceuticals	$3M	0.9
34	EPC	EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$1.3B	0.9
35	TXMD	TherapeuticsMD, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$24M	0.9
36	NL	NLI HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$339M	0.9
37	LTBR	LIGHTBRIDGE CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$214M	0.9
38	RMTI	ROCKWELL MEDICAL, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$32M	0.9
39	AIM	AIM IMMUNOTECH INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$7M	0.9
40	CATX	PERSPECTIVE THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$304M	0.9
41	NEUP	Neuphoria Therapeutics Inc. FY · 2025-06-30 Analysis WACC DCF	Pharmaceuticals	$18M	1.0
42	OLN	Olin Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	1.0
43	CPHI	CHINA PHARMA HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$37M	1.0
44	CRON	CRONOS GROUP INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.2B	1.1
45	AKAN	AKANDA CORP. FY · 2024-12-31 Analysis WACC DCF	Pharmaceuticals	$5M	1.1
46	ALTO	ALTO INGREDIENTS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$289M	1.1
47	ALB	ALBEMARLE CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$12.0B	1.1
48	SCL	STEPAN COMPANY FY · 2025-12-31 Analysis WACC DCF	Other	$1.4B	1.1
49	EMN	EASTMAN CHEMICAL CO TTM · 2026-06-30 Analysis WACC DCF	Other	$7.2B	1.2
50	KRO	KRONOS WORLDWIDE, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$876M	1.2
51	SNGX	SOLIGENIX, INC. FY · 2024-12-31 Analysis WACC DCF	Pharmaceuticals	$8M	1.2
52	LODE	Comstock Inc. FY · 2025-12-31 Analysis WACC DCF	Other	$168M	1.2
53	DOW	DOW INC. FY · 2025-12-31 Analysis WACC DCF	Other	$20.5B	1.2
54	AVXL	ANAVEX LIFE SCIENCES CORP. FY · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$138M	1.2
55	FUL	FULLER H B CO TTM · 2026-08-29 Analysis WACC DCF	Other	$2.7B	1.2
56	SRPT	SAREPTA THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.9B	1.2
57	NEOG	Neogen Corporation FY · 2026-05-31 Analysis WACC DCF	Biotechnology	$2.6B	1.2
58	INVA	INNOVIVA, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.5B	1.2
59	MTX	MINERALS TECHNOLOGIES INC. TTM · 2026-07-05 Analysis WACC DCF	Other	$2.0B	1.3
60	DD	DUPONT DE NEMOURS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$17.6B	1.3
61	LXU	LSB Industries, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$706M	1.3
62	NATR	NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$222M	1.3
63	MRKR	MARKER THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$16M	1.3
64	MYGN	MYRIAD GENETICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$412M	1.4
65	AVNT	AVIENT CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$3.5B	1.4
66	VTRS	VIATRIS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$20.3B	1.4
67	SIGA	Siga Technologies INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$236M	1.4
68	LSTA	LISATA THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11M	1.4
69	IMNN	Imunon, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$6M	1.4
70	GOVX	GEOVAX LABS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$3M	1.5
71	VERU	VERU INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$42M	1.5
72	ACNT	Ascent Industries Co. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$122M	1.5
73	IFF	INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 Analysis WACC DCF	Other	$21.6B	1.5
74	NKTR	Nektar Therapeutics FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.4B	1.6
75	BMRN	BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$10.6B	1.7
76	IOSP	INNOSPEC INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2.4B	1.7
77	BIIB	BIOGEN INC. TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$33.3B	1.8
78	CYRX	CRYOPORT, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$879M	1.8
79	LYB	LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 Analysis WACC DCF	Other	$19.4B	1.8
80	REX	REX AMERICAN RESOURCES CORPORATION TTM · 2026-07-31 Analysis WACC DCF	Other	$1.4B	1.8
81	FTLF	FITLIFE BRANDS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$86M	1.8
82	CAPR	CAPRICOR THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$455M	1.8
83	PFE	PFIZER INC TTM · 2026-06-28 Analysis WACC DCF	Pharmaceuticals	$161.2B	1.9
84	FSI	FLEXIBLE SOLUTIONS INTERNATIONAL INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$77M	1.9
85	CF	CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$16.9B	1.9
86	MNOV	MEDICINOVA, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$75M	2.0
87	LXFR	LUXFER HOLDINGS PLC TTM · 2026-03-29 Analysis WACC DCF	Other	$465M	2.1
88	CRVO	CervoMed Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$49M	2.1
89	RIGL	RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$917M	2.2
90	ABVC	ABVC BioPharma, Inc. FY · 2024-12-31 Analysis WACC DCF	Pharmaceuticals	$27M	2.2
91	ABEO	ABEONA THERAPEUTICS INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$282M	2.2
92	ROG	ROGERS CORP TTM · 2026-03-31 Analysis WACC DCF	Other	$2.6B	2.2
93	CBT	Cabot Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$3.9B	2.2
94	LFVN	LIFEVANTAGE CORP FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$76M	2.2
95	REGN	REGENERON PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$76.9B	2.4
96	NTLA	INTELLIA THERAPEUTICS, INC. FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$1.8B	2.5
97	NAGE	NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$213M	2.6
98	ACAD	ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$3.4B	2.6
99	UG	UNITED-GUARDIAN, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$32M	2.8
100	PPG	PPG INDUSTRIES INC TTM · 2026-03-31 Analysis WACC DCF	Other	$23.1B	2.8